UCLA Semel Institute for Neuroscience and Human Behavior, 760 Westwood Plaza, Room 68-251, Los Angeles, CA 90024, USA.
JAMA. 2010 May 19;303(19):1929-37. doi: 10.1001/jama.2010.607.
Tourette disorder is a chronic and typically impairing childhood-onset neurologic condition. Antipsychotic medications, the first-line treatments for moderate to severe tics, are often associated with adverse effects. Behavioral interventions, although promising, have not been evaluated in large-scale controlled trials.
To determine the efficacy of a comprehensive behavioral intervention for reducing tic severity in children and adolescents.
DESIGN, SETTING, AND PARTICIPANTS: Randomized, observer-blind, controlled trial of 126 children recruited from December 2004 through May 2007 and aged 9 through 17 years, with impairing Tourette or chronic tic disorder as a primary diagnosis, randomly assigned to 8 sessions during 10 weeks of behavior therapy (n = 61) or a control treatment consisting of supportive therapy and education (n = 65). Responders received 3 monthly booster treatment sessions and were reassessed at 3 and 6 months following treatment.
Comprehensive behavioral intervention.
Yale Global Tic Severity Scale (range 0-50, score >15 indicating clinically significant tics) and Clinical Global Impressions-Improvement Scale (range 1 [very much improved] to 8 [very much worse]).
Behavioral intervention led to a significantly greater decrease on the Yale Global Tic Severity Scale (24.7 [95% confidence interval {CI}, 23.1-26.3] to 17.1 [95% CI, 15.1-19.1]) from baseline to end point compared with the control treatment (24.6 [95% CI, 23.2-26.0] to 21.1 [95% CI, 19.2-23.0]) (P < .001; difference between groups, 4.1; 95% CI, 2.0-6.2) (effect size = 0.68). Significantly more children receiving behavioral intervention compared with those in the control group were rated as being very much improved or much improved on the Clinical Global Impressions-Improvement scale (52.5% vs 18.5%, respectively; P < .001; number needed to treat = 3). Attrition was low (12/126, or 9.5%); tic worsening was reported by 4% of children (5/126). Treatment gains were durable, with 87% of available responders to behavior therapy exhibiting continued benefit 6 months following treatment.
A comprehensive behavioral intervention, compared with supportive therapy and education, resulted in greater improvement in symptom severity among children with Tourette and chronic tic disorder.
clinicaltrials.gov Identifier: NCT00218777.
抽动障碍是一种慢性的、通常会造成损害的儿童期起病的神经疾病。抗精神病药物是治疗中重度抽动的一线药物,但往往伴随着不良反应。行为干预虽然有前景,但尚未在大规模对照试验中进行评估。
确定综合性行为干预对减少儿童和青少年抽动严重程度的疗效。
设计、地点和参与者:2004 年 12 月至 2007 年 5 月期间,从 126 名患有致残性抽动或慢性抽动障碍的 9 至 17 岁儿童中进行了随机、观察者盲、对照试验,将他们随机分配到 8 次为期 10 周的行为治疗(61 名)或对照组治疗(支持性治疗和教育,65 名)。应答者接受了 3 次每月的强化治疗,并在治疗结束后 3 个月和 6 个月进行了重新评估。
综合性行为干预。
耶鲁总体抽动严重程度量表(范围 0-50,得分>15 表示存在临床显著的抽动)和临床总体印象-改善量表(范围 1[非常改善]至 8[非常恶化])。
与对照组相比,行为干预组在耶鲁总体抽动严重程度量表上的下降幅度显著更大(从基线到终点,24.7[95%置信区间{CI},23.1-26.3]至 17.1[95% CI,15.1-19.1])(P<0.001;组间差异,4.1;95%CI,2.0-6.2)(效应大小=0.68)。与对照组相比,接受行为干预的儿童中有更多的人被评定为非常或明显改善(分别为 52.5%和 18.5%;P<0.001;需要治疗的人数=3)。失访率低(12/126,9.5%);4%的儿童报告抽动恶化(5/126)。治疗效果持久,87%的可用行为治疗应答者在治疗结束后 6 个月仍继续受益。
与支持性治疗和教育相比,综合性行为干预可使抽动障碍和慢性抽动障碍儿童的症状严重程度得到更大程度的改善。
clinicaltrials.gov 标识符:NCT00218777。